BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9140162)

  • 1. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
    Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
    Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
    Wu XM; Liao YW; Ji KQ; Li GF; Zang B
    J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
    Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
    Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
    Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
    Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
    Borgström A; Axelson J; Ihse I; Rehfeld JF
    Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
    Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
    Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
    Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
    Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCK stimulates growth of both the pancreas and the liver.
    Ohlsson B; Rehfeld JF; Axelson J
    Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous cholecystokinin plays a role in down-regulation of pancreatic amylase independent of dietary carbohydrate in rats.
    Hara H; Ohyama S; Hira T
    Regul Pept; 2001 Jun; 99(2-3):103-10. PubMed ID: 11384771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devazepide-induced hyperplasia in the rat liver and bile ducts.
    Ohlsson B; Axelson J; Rehfeld JF; Ihse I
    Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterochromaffin-like cells in rat stomach respond to short-term infusion of high doses of cholecystokinin but not to long-term, sustained, moderate hyperCCKemia caused by continuous cholecystokinin infusion or pancreaticobiliary diversion.
    Nylander AG; Chen D; Lilja I; Axelson J; Ihse I; Rehfeld JF; Sundler F; Håkanson R
    Scand J Gastroenterol; 1993 Jan; 28(1):73-9. PubMed ID: 8430275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt.
    Ohlsson B; Yusa T; Rehfeld JF; Lundquist I; Ihse I; Axelson J
    Pancreas; 2000 Mar; 20(2):170-6. PubMed ID: 10707933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.